Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kaitlyn J. Andreano"'
Autor:
Donald P. McDonnell, John D. Norris, Ching-yi Chang, Suzanne E. Wardell, Sarah Sammons, Myles Brown, Rinath Jeselsohn, Steffi Oesterreich, Sandeep Artham, Rachid Safi, Sunghee Park, Jennifer G. Baker, Kaitlyn J. Andreano
The estrogen receptor (ER/ESR1) is expressed in a majority of breast cancers and drugs that inhibit ER signaling are the cornerstone of breast cancer pharmacotherapy. Currently, aromatase inhibitors are the frontline endocrine interventions of choice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e02837e68b422e6bbee28a3fb031fa
https://doi.org/10.1158/1535-7163.c.6542740
https://doi.org/10.1158/1535-7163.c.6542740
Autor:
Donald P. McDonnell, John D. Norris, Ching-yi Chang, Suzanne E. Wardell, Sarah Sammons, Myles Brown, Rinath Jeselsohn, Steffi Oesterreich, Sandeep Artham, Rachid Safi, Sunghee Park, Jennifer G. Baker, Kaitlyn J. Andreano
Supplemental Figure 1: Structures of clinically relevant compounds used in this study. Supplemental Figure 2: Cells expressing both the ERWT and ERmuts have similar pharmacological responses to antiestrogens when compared to cells only expressing ERW
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b94a5c88ad45aa9476da6ffd8fc2fb
https://doi.org/10.1158/1535-7163.22520716
https://doi.org/10.1158/1535-7163.22520716
Autor:
Kaitlyn J, Andreano, Jennifer G, Baker, Sunghee, Park, Rachid, Safi, Sandeep, Artham, Steffi, Oesterreich, Rinath, Jeselsohn, Myles, Brown, Sarah, Sammons, Suzanne E, Wardell, Ching-Yi, Chang, John D, Norris, Donald P, McDonnell
Publikováno v:
Mol Cancer Ther
The estrogen receptor (ER/ESR1) is expressed in a majority of breast cancers and drugs that inhibit ER signaling are the cornerstone of breast cancer pharmacotherapy. Currently, aromatase inhibitors are the frontline endocrine interventions of choice